HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 1,393.00
-1.00 (-0.07%)
At close: Oct 23, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 63.42 billion as of October 23, 2026. It is the 30,389th most valuable company in the world and the 1,609th biggest in South Korea. Its market cap has decreased by 18.24% in one year.
Market Cap
63.42B
Enterprise Value
45.13B
Revenue
14.71B
Global Rank
Country Rank
#1,609 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 63.42B, an increase of 266.80%. That is a compound annual growth rate of 5.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 63.42B | -19.66% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 196.66B |
| 3billion | 167.70B |
| GC Medical Science | 86.51B |
| Inventera | 72.29B |
| Protia | 69.74B |
| Cytogen | 61.17B |
| GENINUS | 56.84B |
| Seoulin Bioscience | 34.05B |